| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $628.3M | +6.2% | +18.7% |
| Cost of Revenue | $179.2M | +4.5% | +32.4% |
| Gross Profit | $449.1M | +6.9% | +14.0% |
| R&D Expense | $176.6M | -2.8% | +16.6% |
| SG&A Expense | $60.1M | +1.0% | +14.3% |
| Operating Income | -$18.4M | +71.8% | +33.9% |
| Interest Expense | $801K | -45.6% | -64.8% |
| Pre-tax Income | $1.4M | +103.1% | +119.0% |
| Income Tax | $3.4M | -14.5% | +25.9% |
| Net Income | -$2.0M | +95.7% | +79.5% |
| EPS (Basic) | -$0.02 | +96.6% | +84.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $834.1M | +28.9% | +23.9% |
| Accounts Receivable | $416.5M | +19.1% | +24.5% |
| Current Assets | $2.93B | +1.0% | +4.9% |
| Total Assets | $3.57B | +0.7% | +10.6% |
| Current Liabilities | $558.0M | +9.5% | -66.0% |
| Total Liabilities | $678.2M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $325.5M | — | — |
| Capital Expenditures | $3.8M | — | — |
| Investing Cash Flow | $372.2M | — | — |
| Financing Cash Flow | -$362.1M | — | — |
| Free Cash Flow | $321.7M | — | — |
| -60.6% |
| Stockholders' Equity | $2.89B | -1.9% | +92.3% |